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ABSTRACT: The development of long-lived luminescent nano-
particles for lifetime imaging is of wide interest as luminescence
lifetime is environmentally sensitive detection independent of
probe concentration. We report novel iridium-coated gold
nanoparticles as probes for multiphoton lifetime imaging with
characteristic long luminescent lifetimes based on iridium
luminescence in the range of hundreds of nanoseconds and a
short signal on the scale of picoseconds based on gold allowing
multichannel detection. The tailor-made IrC6 complex forms
stable, water-soluble gold nanoparticles (AuNPs) of 13, 25, and
100 nm, bearing 1400, 3200, and 22 000 IrC6 complexes per
AuNP, respectively. The sensitivity of the iridium signal on the environment of the cell is evidenced with an observed variation
of lifetimes. Clusters of iridium nanoparticles show lifetimes from 450 to 590 ns while lifetimes of 660 and 740 ns are an average
of diﬀerent points in the cytoplasm and nucleus. Independent luminescence lifetime studies of the nanoparticles in diﬀerent
media and under aggregation conditions postulate that the unusual long lifetimes observed can be attributed to interaction with
proteins rather than nanoparticle aggregation. Total internal reﬂection ﬂuorescence microscopy (TIRF), confocal microscopy
studies and 3D luminescence lifetime stacks conﬁrm the presence of bright, nonaggregated nanoparticles inside the cell.
Inductively coupled plasma mass spectrometry (ICPMS) analysis further supports the presence of the nanoparticles in cells.
The iridium-coated nanoparticles provide new nanoprobes for lifetime detection with dual channel monitoring. The
combination of the sensitivity of the iridium signal to the cell environment together with the nanoscaﬀold to guide delivery oﬀer
opportunities for iridium nanoparticles for targeting and tracking in in vivo models.
■ INTRODUCTION
Multiphoton imaging is fast becoming the most widely used
optical microscopy for in vivo experiments with breakthroughs
in medical diagnostics, speciﬁcally in quantiﬁcation of
angiogenesis and cancer metastasis, reaching to several
millimeters in depth detection, thus providing invaluable
information on tumor vasculature and tumor microenviron-
ment.1−3 Combining multiphoton excitation with lifetime
imaging microscopy reveals a wealth of additional information,
which is independent of the probe concentration but sensitive
to local changes of the environment.4,5 Nanoparticles in
imaging applications have gained a lot of attention for
providing high sensitivity, leading to improved spatial
resolution while requiring lower concentrations compared to
molecular probes and allowing versatile targeting vector
attachment.6,7 In multiphoton imaging, their applications
have been restricted in the selection of the organic dye or
the properties of the materials, which have short-lived
luminescence signals.8−12 There is a strong interest for the
development of probes with long excited state lifetimes, which
can be gated from short-lived signals associated with
autoﬂuorecence, expanding sensitivity in signal detection.13
Iridium cyclometalated complexes are popular luminescent
probes for biological imaging,14,15 with a luminescent signal
that can be tuned by modiﬁcation of their ligand framework
which also inﬂuences localization in cell organelles.16,17 The
power of detection by lifetime imaging of metal complexes18 is
demonstrated in iridium complexes in tumor imaging for
cancer metastasis19 and hypoxia.20
We have been interested in the development of nanosized
probes based on gold scaﬀold and luminescent transition metal
complexes in order to translate the attractive luminescent
properties of the metal complexes to the nanosized probe.21−23
The coating of transition metal allows covering of the gold
surface with hundreds to thousands of metal complexes which
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give a strong characteristic luminescent signal. Gold nano-
particles have unique optical properties and can easily
incorporate more than one type of imaging or targeting
agent, which allows them to be used as multifunctional
nanoplatforms for both imaging and cancer therapies.24 The
gold nanoparticle scaﬀold is ideal as a multimodal probe which
can be detected by electron microscopy techniques as well as
reﬂectance microscopy, which is highly advantageous for 100
nm gold nanoparticles to be detected as single, nonaggregated
particles within the microscope diﬀraction limit.25,26 Even
though the characteristic surface plasmon resonance of the
gold nanospheres has been used extensively as signal
detection,27 there is little investigation in monitoring gold
nanoparticles by lifetime imaging.28
In this paper, we introduce iridium coated nanoparticles for
multichannel lifetime imaging using multiphoton excitation.
We have developed a novel nanoprobe based on a luminescent
iridium complex with long legs for attachment to gold (Scheme
1). It was previously shown that the distance of the
luminescent center from the gold nanoparticle enhances the
lifetime properties of the ruthenium probes.22 Incorporating
the hexyl chain on the phenylpyridine was designed to increase
hydrophobicity of the iridium complex and stabilization onto
gold, increasing signal and therefore proposing better
permeability across the cell membrane.29,30 We illustrate in
this paper detection of the characteristic long lifetime of the
iridium complex and the short lifetime detected from the gold
resonance signal by lifetime imaging microscopy. We have
examined diﬀerent sizes of gold nanoparticles (13, 25, and 100
nm) functionalized with the iridium probe and their uptake in
live HeLa cells with lifetime imaging, optical and electron
based techniques. The sizes were selected based on previous
studies which show that the coated gold nanoparticles within
the 10- 60 nm range show high uptake into cancer cells.31−33
We present the full characterization of the nanoparticles, their
photophysical properties which reveal unprecedented long
iridium lifetimes in the cell and a variation of lifetime based on
the environment. The results of nanoparticle localization in
cells are also supported by total internal reﬂection ﬂuorescence
microscopy (TIRF), electron microscopy as well as inductively
coupled plasma mass spectrometry (ICPMS) analysis.
■ RESULTS AND DISCUSSION
The iridium probe, IrC6, was synthesized from the iridium
dimer, [Ir(ppy-C6)2(μ-Cl)]2, and a surface active bipyridine
ligand with long legs for attachment to gold (Scheme 2). The
2-(hexylphenyl)-pyridine ligand was synthesized based on the
method of Ackermann et al.34 and conjugated to iridium
trichloride hydrate to form the iridium dimer [Ir(ppy-C6)2(μ-
Cl)]2. The ﬁnal step involved conjugation of the bipyridine
ligand to the dimer to form IrC6..
35 The iridium complex was
fully characterized and its photophysical properties inves-
tigated.
The IrC6 complex showed absorption bands in the UV−vis
region (Figure S1 in the Supporting Information (SI)) with
intense bands at 230 and 260 nm arising from the 1π−π*
transitions from the ligands and a tail with shoulders at 300
and 350 nm, extending to 400 nm, which are attributed to
1MLCT transitions in accordance with previous assignments.36
Excitation of a solution of IrC6 in water at 350 or 375 nm
produced an emission broad peak with a maximum at 580 nm
(Figure 1) which is attributed to a triplet charge transfer state
which usually has contributions of 3MLCT and 3LMCT.37 The
excitation spectrum showed the characteristic absorption
proﬁle, revealing that excitation in the range up to 430 nm is
possible to provide emission which makes this complex a
suitable candidate for conventional confocal microscopes.
Upon addition of Zonyl FSA (10 μL 10% in water) to a
solution of IrC6 in water (30 μL) a 10 nm bathochromic shift
was observed in emission (Figure S2 in the SI). The shift is
indicative of an interaction of the probe with the surfactant,
changing the environment around the IrC6 probe and aﬀecting
the charge transfer transition. The quantum yield of a solution
of IrC6 was found to be 4% and the luminescence lifetime was
analyzed with three components to be 42 ns (a1 = 6%) 166 ns
(a2 = 45%), 428 ns (a3 = 49%). These data agree with phenyl-
pyridine iridium complexes previously studied.36,38,39 Upon
addition of Zonyl surfactant to a solution of IrC6 a reduction of
the lifetime is observed, notably a 160 ns decrease of the long-
lived component [49 ns (a1 = 3%), 147 ns (a2 = 35%), 324 ns
Scheme 1. Schematic for Procedure of Coating AuNPs with
Fluorinated Surfactant and IrC6
Scheme 2. Synthetic Route for Preparation of IrC6
Figure 1. Photophysical characterization of IrC6 in water. Excitation
spectrum (dotted line) λem = 580 nm and luminescence spectra (solid
line) of 30 μM Ir(C6) in water λexc = 375 nm. Spectra are corrected
for PMT and instrument response.
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(a3 = 62%)] (Table S1 in the SI). This diﬀers from the eﬀect
of the surfactant on a ruthenium complex, where a 25%
lifetime enhancement was seen upon addition of the Zonyl
surfactant.22 This could be due to the eﬀect of the hexyl chain
and the lower charge of the complex in the interaction with the
surfactant.
Monodisperse, water-soluble 13, 25, and 100 nm gold
nanoparticles (AuNP13, AuNP25, and AuNP100) were
synthesized using the improved Turkevich method, with slight
modiﬁcations.40−42 The protocol involved synthesizing
AuNP13 seeds by a citrate reduction method, followed by a
growth procedure to give AuNP25 and AuNP100 nano-
particles stabilized with citrate anions. These AuNPs were
characterized by surface plasmon resonance (SPR), dynamic
light scattering (DLS), zeta potential, and transmission
electron microscopy (TEM).
AuNP13, AuNP25, and AuNP100 showed a characteristic
SPR band with a maximum, λmax (H2O) at 517, 519, and 556
nm, respectively. AuNP13, AuNP25, and AuNP100 were sized
by DLS analysis. The number distribution indicated sizes at 13
± 3 nm (PDI = 0.07), 18 ± 5 nm (PDI = 0.05) and 80 ± 20
nm (PDI = 0.03), respectively (Table S2 in the SI). TEM
images showed sizes of 15, 25, and 95 nm for AuNP13,
AuNP25, and AuNP100 respectively, which agree with the
DLS results (Figure S3 in the SI). Prior to coating with the
IrC6 complex, a ﬂuorinated surfactant, Zonyl FSA was used to
stabilize the nanoparticle surface and prevent aggregation
induced by positively charged metals by direct replacement of
the negative citrate ions. The surfactant-modiﬁed nanoparticles
were isolated by centrifugation to give Z·AuNP13, Z·AuNP25,
and Z·AuNP100. The IrC6 complex is then added to the
colloid. A solution of IrC6 in MeOH (1 mM) was titrated in
2.5 μL aliquots to an aqueous solution of the corresponding
Zonyl-coated nanoparticles and the SPR shift was monitored
within the visible region (Figure 2). The observed red shift in
the SPR band conﬁrmed the modiﬁcation of the gold surfaces
and allowed us to identify the saturation point of the maximum
concentration of the iridium probe before aggregation of the
particle. Addition of 20 μL, 40 and 30 μL of 1 mM IrC6 into Z·
AuNP13, Z·AuNP25, and Z·AuNP100 resulted in shifts of 5
(λmax = 522 nm), 6 (λmax = 525 nm), and 2 (λmax = 558 nm)
nm, respectively. The iridium-coated nanoparticles were
isolated by size exclusion chromatography (Sephadex G10)
to remove any excess molecular probe and produced IrC6·
AuNP13, IrC6·AuNP25 and IrC6·AuNP100. Following chro-
matography for isolation of these nanoparticles, the λmax of the
SPR band remained unchanged, showing that the surface
coating has not been altered by the removal of the excess metal
complex (Figure S4 in the SI).
DLS analysis of the iridium-coated nanoparticles showed
that the size of the AuNPs did not signiﬁcantly change when
coated with Zonyl and IrC6 (Table 1). Analysis of TEM images
showed spherical particles with estimated diameters of 15, 25,
and 95 nm for IrC6·AuNP13, IrC6·AuNP25, and IrC6·
AuNP100, respectively (Figure 3). Elemental composition of
the nanoparticles by ICPMS showed a coating of 1400, 3200,
and 22 000 IrC6 complexes per AuNP for IrC6·AuNP13, IrC6·
AuNP25, and IrC6·AuNP100, respectively.
The photophysical properties of these functionalized
nanoparticles were investigated by steady state and time-
resolved spectroscopy to identify any changes in behavior of
the IrC6 complex when conjugated to the surface of the gold
nanoparticle. All three diﬀerent sized gold nanoparticles, IrC6·
AuNP13, IrC6·AuNP25, and IrC6·AuNP100 were emissive
upon excitation at either 350, 375, or 405 nm, with a λmax at
590 nm. The emission maximum was red-shifted by 10 nm in
comparison to the free complex in water, which showed an
emission λmax at 580 nm, the shift being the same as in the
presence of surfactant, reﬂecting the environment around the
iridium probe. The luminescence spectrum of IrC6·AuNP25 is
shown in Figure 4 and the spectra for the rest of the
nanoparticles can be found in the Supporting Information
(Figure S5 in th SI).
The excitation spectra displayed the iridium characteristic
bands and the shoulders around 400 and 420 nm which are
responsible for the observed emission. The luminescence
lifetime of IrC6·AuNP25 in water was analyzed with three
components to be 40 ns (a1 = 5%), 160 ns (a2 = 42%), and
330 ns (a3 = 53%). Similar lifetimes were found for IrC6 ·
AuNP13 and IrC6 ·AuNP100 respectively (Table S3, SI).
Interestingly, the luminescence lifetimes of the iridium-coated
gold nanoparticles reﬂect the reduction of the signal observed
by the inﬂuence of the Zonyl surfactant environment rather
than any quenching from the gold nanoparticle. The inﬂuence
of the Zonyl surfactant is also evident in the observed shift of
the λmax in the emission spectrum of the nanoparticles in
comparison with the IrC6 molecular probe. The quantum
Figure 2. UV/vis titration of 1 mM IrC6 into 1.6 nM Z·AuNP25 in
water (left) and λmax of SPR peak vs volume of IrC6 (20 μM) added
(right).
Table 1. Dynamic Light Scattering Data for IrC6·AuNP in
Water, Showing Polydispersity Index (PDI) and Sizes by
Number and Intensity Distributions
PDI size by number/nm size by intensity/nm
IrC6·AuNP13 0.27 17 ± 4 28 ± 10
IrC6·AuNP25 0.18 22 ± 6 40 ± 18
IrC6·AuNP100 0.02 90 ± 22 110 ± 25
Figure 3. Transmission electron microscope images of (a) IrC6·
AuNP13, (b) IrC6·AuNP25, and (c) IrC6·AuNP100. Images were
acquired on JOEL 1200 EX transmission electron microscopy. Scale
bars are 15, 25, and 100 nm.
Journal of the American Chemical Society Article
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yields of the IrC6·AuNP13 and IrC6·AuNP25 nanoparticles
were found to be 5%, using an integrated sphere and the Zonyl
coated gold nanoparticles as reference sample with an SPR to
match the SPR peak of IrC6-coated nanoparticles (Figure S6,
SI). Determination of number of AuNPs per cell was carried
out by ICPMS. It was found that there were approximately
67 000, 26 000, and 5100 AuNPs per cell for IrC6·AuNP13,
IrC6·AuNP25, and IrC6·AuNP100, respectively (SI). Further
ICPMS analysis of mitochondria and vesicles isolated by cell
fractionation show comparable accumulation in both mito-
chondria and vesicles which is increased by incubation time
(from 6 to 24 h, Figure S16)
To examine the suitability of the nanoparticles for two
photon imaging, we investigated the two-photon absorption
cross sections and the power dependence analysis of their
luminescence. The colloidal solution of IrC6·AuNP25 was
immobilized in 0.1% agarose gel to restrict the particle
movement through the laser beam at a fast rate due to the
Brownian motion. The laser dependence studies were
calculated on four diﬀerent areas of the agarose gel and the
average was calculated. Two-photon excitation at 760 nm
produced the same emission as one-photon excitation (Figure
5). The integrated emission intensity was plotted against the
laser intensity showing a linear ﬁt in a log−log plot. The slope
of the linear ﬁt was calculated to be 2, demonstrating the two-
photon process which is taking place. The two-photon
absorption cross sections (σ2) were calculated for both the
IrC6 probe in methanol and IrC6·AuNP25 in 0.1% agarose gel
using the equation below, which compares the luminescence
intensity of the samples to that of a reference standard,
rhodamine B in methanol.43
σ
ϕ
ϕ
σ= ∑
∑
λ
λ
λ
λ
C
C
I
I
(FI /( FI ))
(FI /( FI ))2s
r
s
s
r
r r
s s
r
s
2r
where r and s stand for the reference standard and sample
respectively, σ2 for two-photon absorption cross section, c for
concentration, FIλ and FIλ are the ﬂuorescence intensity at the
wavelength λ for two-photon and one-photon, respectively.
ΣFL describes the integrated intensity of the one-photon
ﬂuorescence spectra, and ϕ is the one-photon ﬂuorescence
quantum yield, which is assumed to be the same under two-
photon conditions.44 The results showed an absorption cross
section of 38 GM (GM = 10−50 cm4 s photon−1) for the IrC6 in
methanol and 2 × 103 GM of IrC6·AuNP25. The absorption
cross section calculated for IrC6 agrees with similar iridium
compounds.45 The absorption cross section of IrC6·AuNP25,
is unprecedently high for any iridium-based luminescence
signal and is attributed to the enhancement by the gold surface
plasmon resonance.
Two-photon lifetime imaging of live HeLa cells treated with
iridium nanoparticles was employed to monitor long and short
lifetimes in two diﬀerent channels for nanoparticle localization.
The lifetime-based detection of the HeLa cells in these two
channels is shown in Figure 6 for IrC6·AuNP25, IrC6·
AuNP100, and IrC6·AuNP13. One channel was set to detect
the long component of the iridium signal in the hundreds of
nanoseconds range and the second channel was set to detect a
short-lived signal in the tens of picosecond range which
became apparent that this originated from the gold nano-
particle surface plasmon resonance, supported by the lifetime
decay (Figure S7, SI). These short-lived picosecond lifetimes,
in the range of 20−120 ps, were detected in HeLa cells
showing uptake of IrC6 ·AuNPs, this can be seen in yellow in
Figure 6. The detection in the nanosecond range reveal
lifetimes which were longer than the iridium nanoparticles in
solution. We analyzed these images to ﬁnd lifetimes in the
range of 450−1000 ns, which can be seen in red in Figure 6.
The lifetimes displayed in the long-lived channel are the long
component (τ3). The three sizes of nanoparticles show a
similar pattern, with uptake dominated in the cytoplasm of the
cell and some presence in the nucleus. which is more dominant
for IrC6·AuNP25 and IrC6·AuNP13. The uptake of IrC6·
AuNP100 diﬀers from that of IrC6·AuNP13 and IrC6·AuNP25
with more clusters of nanoparticles being formed around the
outer cell membrane, clearly evidenced by the gold signal. The
clustering could be due to the larger size of nanoparticles
slowing down uptake and conﬁning these nanoparticles to the
cellular membrane, slowing down uptake due to steric
hindrance and receptor saturation.33 Stacks of the images
Figure 4. Steady-state emission λexc = 375 nm (solid line), UV/vis
absorption (dashed line), and excitation, λem = 590 nm (dotted line)
spectra of 1.6 nM IrC6·AuNP25. Spectra are corrected for PMT and
instrument response.
Figure 5. Emission spectra produced from one photon excitation λexc
= 375 nm (dotted line) and two-photon excitation λexc = 760 nm
(solid line) of IrC6·AuNP25 in agarose gel. Spectra have been
normalized. Inset: Power dependence study showing integrated
intensity as a function of laser power for IrC6 ·AuNP25 in agarose
gel, gradient is 2.068 (R = 0.997). λexc = 760 nm.
Journal of the American Chemical Society Article
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Figure 6. Two photon, two channel lifetime microscopy of IrC6·AuNP25 (top), IrC6·AuNP100 (middle), and IrC6·AuNP13 (bottom) in live HeLa
cells. (A) Intensity image. (B) Image of iridium signal showing a lifetime range of 450−1000 ns (red). (C) Image of short-lived signal showing a
lifetime range of 20−120 ps, from the gold. HeLa cells incubated with 0.16 nM IrC6·AuNP25 for 3 h and 0.45 nM IrC6·AuNP13 and 3 pM IrC6·
AuNP100 for 5 h. λexc = 760 nm, scale bar = 20 μm.
Figure 7. Mapping the iridium signal of iridium-coated nanoparticles in live HeLa cells: IrC6·AuNP25 (left), IrC6·AuNP100 (middle), and IrC6·
AuNP13 (right). Image of signal with a lifetime range of 700−1000 ns (red), 600−690 ns (green), and 450−590 ns (blue). HeLa cells incubated
with 0.16 nM IrC6·AuNP25 for 3 h and 0.45 nM IrC6·AuNP13 and 3 pM IrC6·AuNP100 for 5 h. λexc = 760 nm, scale bar = 20 μm.
Journal of the American Chemical Society Article
DOI: 10.1021/jacs.8b05105
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throughout the cell show the nanoparticle localization (SI,
Figure S17).
We investigated the lifetime variation within the cell. We
identiﬁed three areas to map the variation of the τ2 of the
iridium nanoparticle signal in the cell: cytoplasm, nucleus and
nanoparticle clusters (Figure 7). The lifetime variation was
mapped by taking the average of at least 10 lifetimes of the
diﬀerent areas. It was found that the iridium lifetime in the
cytoplasm extends to 665, 650, and 660 ns with a standard
deviation of ±75 ns. This range was evident for all the
nanoparticles, IrC6·AuNP13, IrC6·AuNP25, and IrC6·
AuNP100. These average lifetimes observed for the iridium
long component show an increase of 320 ± 10 ns from the
iridium-coated gold nanoparticles recorded in water. The
largest increase seen is within the nucleus of the cell, in some
other areas of the cell (colored in red) where the average
lifetimes observed are 740 ± 80 ns (Figure 7). These lifetimes
are higher by 400 ns from the iridium-coated gold nano-
particles recorded in water. Evidence of nuclear localization of
some of the nanoparticles is further supported by confocal
luminescence imaging using Hoechst nuclear stain and
recording z-stacks of the iridium and Hoechst signals (SI,
Figures S14 and S15). The presence of the long-lived signal in
the nucleus is much weaker for the IrC6 ·AuNP100 with their
localization conﬁned to the cell membrane and cytoplasm but
it is sensitive to be detected for the smaller nanoparticles
(Figure S8, SI) whose localization in the nucleus can be more
challenging to be detected with other microscopy techniques
which require high concentrations and accumulations of
particles. It was clear that clusters of nanoparticles seem to
be accompanied by lifetimes highlighted in 450−590 ns
(colored blue). The lifetime variation at this range shows more
clusters present in the IrC6 ·AuNP25 than for the IrC6·
AuNP13.
To further understand the eﬀect of the change in lifetime of
these nanoparticles, the lifetimes of the iridium-functionalized
nanoparticles were recorded in full cell media (DMEM with
10% fetal bovine serum, FBS, 5% penicillin−streptomycin−
glutamine) and FBS (90% v/v) to emulate the conditions in a
cell (Table 2). It is clearly observed that the iridium
nanoparticles showed a large increase in lifetime when
measured in cell media and FBS serum with the IrC6·
AuNP25 showing the largest increase of 145 and 265 ns when
measured in cell media and FBS respectively. The SPR of IrC6·
AuNP25 was checked by UV/vis to prove no aggregation was
occurring when placed in cell media (Figure S9, SI). We
postulate that the long lifetimes of the iridium nanoparticles in
cells reﬂect their interaction with cellular chemicals and
proteins. The lifetime of the molecular complex IrC6 is also
aﬀected by cell media and FBS although the increase is not as
enhanced as seen on the nanoparticles.
To assess nanoparticle clustering in the cells, we examined
the average lifetime of these clusters in the cells for the
diﬀerent sized nanoparticles and compared them with
nanoparticles in solution, forced into aggregation by addition
of 50 mM Tris buﬀer (Figure S10, SI). The lifetimes of
aggregated particles in solution showed an increase in the
contribution of the shorter component to 170 ns (63%), in
comparison to 160 ns (42%) for IrC6·AuNP25 in water and a
decrease in the long component to 300 ns (33%), in
comparison to 330 ns (53%) for IrC6·AuNP25 in water.
These values are much shorter than the main component
observed in cells, for all three sizes of nanoparticles, which is
over 450 ns. The data conﬁrm that the observed clusters are
indeed nonaggregated nanoparticles. It is therefore concluded
that the nanoparticles have come together during uptake to
form clusters within the cell rather than aggregated particles.
Notably, the iridium lifetime within the cells is clearly longer
than that observed of the nanoparticles in solution. The
lifetimes of the IrC6 probe and the nanoparticles in water are
shown for comparison.
To further analyze the internalization of the IrC6·AuNP25,
we used TIRF microscopy. TIRF provides high-resolution
imaging of the cell surface,46,47 which allowed us to determine
localization of these nanoparticles throughout the cell (Figure
8) as TIRF angle is varied. Clear bright white spots in the
luminescence image (planes 1−5) are attributed to iridium
luminescence from the nonclustered gold nanoparticles on
planes moving upward from the imaging dish. This shows
nanoparticle localization within the cell more speciﬁcally in the
cytoplasm and around the cell membrane, which agrees with
the lifetime imaging studies. Most importantly, the images
show clearly nonaggregated nanoparticles with good reso-
lution. TIRF microscopy is governed by the evanescent wave
with the resolution restricted to 150 nm depth, providing
information inside the cell membrane. TIRF clearly shows
nonclustered, single nanoparticles in each plane.
Transmission electron microscopy images showed the IrC6·
AuNP25 nanoparticles to appear as dark spheres located
throughout the cytoplasm of the cell (Figure S11). They
appeared to be individual spheres with the predicted size of
individual particles, suggesting that no aggregation occurs upon
uptake. The nanoparticles are localized within vesicles
suggesting the mechanism of uptake could be endocytosis.33
These vesicles contain a high number of nanoparticles which
have been taken up together. Since these nanoparticles have
localized in one place, at lower magniﬁcations they may appear
to have formed “clusters” within the cell. The ICPMS results
also support the presence of nanoparticles in vesicles (SI,
Figure S16). The IrC6·AuNP100 showed localization around
the outer and inner cell membrane supporting the two-photon
lifetime imaging studies.
■ CONCLUSIONS
We have shown that surface-active iridium complexes attached
to gold nanoparticles of diﬀerent sizes show characteristically
long luminescence lifetimes and emission in the visible range.
The ﬂuorinated surfactant used to stabilize gold nanoparticles
Table 2. Lifetimes Recorded for Samples in Water, Cell
Media, and FBS Seruma
lifetimes under diﬀerent conditions (ns)
IrC6·AuNP13 IrC6·AuNP25 IrC6 ·AuNP100
water 50 (5%) 40 (5%) 25 (3%)
180 (48%) 160 (42%) 140 (43%)
340 (47%) 330 (53%) 340 (54%)
cell media 13 (5%) 16 (2%) 30 (2%)
120 (15%) 125 (12%) 160 (22%)
450 (80%) 475 (86%) 440 (76%)
FBS serum 14 (5%) 21 (3%) 10 (5%)
121 (17%) 161 (13%) 110 (20%)
515 (78%) 565 (84%) 530 (85%)
aLifetimes were recorded using a 376 nm laser and were ﬁtted with a
χ2 between 1 and 1.1.
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led to reduction in the lifetime of the iridium complex in
solution; however, no further decrease was detected upon
attachment to the diﬀerent sized nanoparticles. The iridium-
coated nanoparticles displayed two-photon luminescence in
agreement with the one-photon spectra and a two-photon
absorption cross section much higher than the molecular probe
attributed to the gold nanoparticle. Two-photon lifetime
imaging of the iridium-coated nanoparticles in cancer cells
demonstrated that detection can be performed in two
channels, one for the long lifetime signal of the iridium
complex in hundreds of nanoseconds and the other for the
short lifetime signal from the gold in tens of picoseconds. The
two-channel detection showed clearly the iridium and gold
signal for all nanoparticle sizes investigated, with uptake being
seen in the cytoplasm and nucleus of the cells. It was found
that the majority of 100 nm AuNPs located around the cell
plasma membrane. Remarkably long lifetimes have been
detected in the cell, with the nanoparticles localized in the
nucleus showing an average of 740 ns. Clusters of the
nanoparticles showed lifetimes of 450−590 ns and are found in
the cytoplasm but not in the nucleus of the cells. The IrC6·
AuNP25 showed more clustering than the IrC6·AuNP13. The
clustering of the nanoparticles was also supported by TEM
images, although nanoparticles in the nucleus were not
detected, possibly due to the small sections of cell slices.
Nuclear localization of small nonaggregated nanoparticles is
challenging but the sensitivity of the luminescence lifetime
signal demonstrated nuclear localization by detecting the long-
lived lifetimes, which was more dominant for the IrC6·AuNP13
and IrC6·AuNP25. We have independently examined the
nanoparticle lifetime variation in solution upon addition of
serum, and it is apparent that lengthening of the lifetimes is
observed which is attributed to interactions of the nano-
particles with biomolecules. Clustering of nanoparticles
showed shorter lifetimes but not as short as aggregated
particles, conﬁrming that these clusters were in fact non-
aggregated particles. Overall, the iridium-coated nanoparticles
are introduced as novel nanoprobes for two-photon lifetime
imaging with unprecedented long lifetimes, providing multi-
channel detection for independent monitoring of the gold
scaﬀold and the iridium signal. The long-lived lifetime signal is
sensitive to the cell environment, providing local information
which can be used for gating speciﬁc biomolecular interactions
and tracking nanoparticles in in vivo models.
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